Apremilast Pediatric Study in Children With Active Oral Ulcers Associated

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease — BEAN

Behçet Disease Clinical Trial

Official title:
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From 2 to Less Than 18 Years of Age With Active Oral Ulcers Associated With Behçet's Disease (BEAN)

Status Recruiting

Clinical Trial Summary

The aim of this study is to estimate the efficacy of apremilast compared to placebo in the treatment of oral ulcers in pediatric participants from 2 to < 18 years of age with oral ulcers associated with Behçet's disease (BD) through week 12.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04528082
Study type	Interventional
Source	Amgen
Contact	Amgen Call Center
Phone	866-572-6436
Email	medinfo@amgen.com
Status	Recruiting
Phase	Phase 3
Start date	September 9, 2021
Completion date	July 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04101604` - Biomarkers of Common Eye Diseases
Terminated	`NCT04609397` - A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease	Phase 2
Not yet recruiting	`NCT05128357` - IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease)
Not yet recruiting	`NCT04126850` - Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis Disease
Recruiting	`NCT05879419` - Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases	Phase 4
Completed	`NCT03209219` - Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis	Phase 3
Completed	`NCT04386824` - Erectile Dysfunction in Patients With Non Ocular Behçet's Disease
Completed	`NCT02648581` - Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease	Phase 2
Recruiting	`NCT06451575` - Thrombophilia and Thrombosis in Behçet's Disease
Recruiting	`NCT04530461` - Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
Not yet recruiting	`NCT06386744` - Dusquetide for the Treatment of Behcet's Disease	Phase 2
Recruiting	`NCT04334031` - Deployment o the Multidisciplinary Prospective Cohort Imminent	N/A
Not yet recruiting	`NCT04105439` - Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
Not yet recruiting	`NCT05715294` - The Effect of Music on Sleep Quality in Behçet's Patients	N/A
Active, not recruiting	`NCT06266247` - How Sirtuin Levels Change During Behçet Disease	N/A
Recruiting	`NCT04959435` - Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
Recruiting	`NCT03837236` - Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease	N/A
Recruiting	`NCT03803462` - Behçet's Disease Overall Damage Index